Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D006801:Humans; D010919:Placebos
D010919:Placebos; D004877:Ergoloid Mesylates